KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Financing Activities (2016 - 2026)

AbbVie has reported Cash from Financing Activities over the past 14 years, most recently at -$4.2 billion for Q4 2025.

  • Quarterly Cash from Financing Activities rose 39.28% to -$4.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.7 billion through Dec 2025, down 144.18% year-over-year, with the annual reading at -$12.7 billion for FY2025, 144.18% down from the prior year.
  • Cash from Financing Activities was -$4.2 billion for Q4 2025 at AbbVie, up from -$4.6 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $10.8 billion in Q1 2024 and troughed at -$9.6 billion in Q4 2022.
  • The 5-year median for Cash from Financing Activities is -$4.3 billion (2023), against an average of -$3.9 billion.
  • Year-over-year, Cash from Financing Activities tumbled 128.95% in 2021 and then skyrocketed 274.73% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$6.3 billion in 2021, then plummeted by 52.0% to -$9.6 billion in 2022, then soared by 53.82% to -$4.4 billion in 2023, then plummeted by 54.21% to -$6.9 billion in 2024, then soared by 39.28% to -$4.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash from Financing Activities are -$4.2 billion (Q4 2025), -$4.6 billion (Q3 2025), and -$2.7 billion (Q2 2025).